Table 2.
Effect of NDGA and Cur on ROS production in HIV-1 latently infected U1 cells.
| Treatment | DCFH-DA (X-fold) |
|---|---|
| NDGA (6 μM) | 1.00 ± 0.10 |
| NDGA (15 μM) | 1.40 ± 0.10 |
| Cur (1 μM) | 1.01 ± 0.22 |
| Cur (10 μM) | 0.91 ± 0.27 |
Effect of NDGA and Cur on ROS production in HIV-1 latently infected U1 cells.
| Treatment | DCFH-DA (X-fold) |
|---|---|
| NDGA (6 μM) | 1.00 ± 0.10 |
| NDGA (15 μM) | 1.40 ± 0.10 |
| Cur (1 μM) | 1.01 ± 0.22 |
| Cur (10 μM) | 0.91 ± 0.27 |